Page 1

WELL Health Achieves Record Revenue and Adjusted EBITDA in Q2-2021 ; with 484 % YoY Revenue Growth ; and 615 % Growth in its Adjusted Gross Profit ● WELL reported record quarterly revenues of $ 61.8 million in Q2-2021 reflecting a 484 % year - over - year ( YoY ) increase compared to Q2-2020 . WELL's growth was mainly driven by the acquisition of CRH Medical Corporation ( " CRH " ) combined with a 432 % YOY increase in the Company's Virtual Services revenue ( ³ ) in the quarter . WELL achieved its third quarter in a row of positive Adjusted EBITDA ( 2 ) , with Adjusted EBITDA ( 2 ) of $ 11.9 million for Q2-2021 , compared to Adjusted EBITDA ( 2 ) loss of $ 0.5 million for Q2-2020 . WELL'S Adjusted Gross Profit ( ¹ ) increased by 615 % to $ 30.2 million in Q2-2021 , as compared to Adjusted Gross Profit ( ¹ ) of $ 4.2 million in Q2-2020 . WELL achieved record Adjusted Gross Margin ( ¹ ) percentage of 48.9 % during Q2-2021 compared to Adjusted Gross Margin ( ¹ ) percentage of 40.0 % in Q2-2020 . WELL's strong outlook for Q3-2021 is attributed to the full contribution of the CRH and MyHealth Partners Inc. ( " MyHealth " ) acquisitions and catapults WELL's estimated proforma annualized revenue run - rate to almost $ 400 million with Adjusted EBITDA ( 2 ) run - rate approaching $ 100 million . Vancouver , B.C. August 12 , 2021 - WELL Health Technologies Corp. ( TSX : WELL ) ( the " Company " or " WELL " ) , a company focused on consolidating and modernizing clinical and digital assets within the primary healthcare sector , announced today its results for the second quarter of 2021 ended June 30 , 2021 . Hamed Shahbazi , Chairman and CEO of WELL commented , " Our practitioner enablement platform and momentum around our acquisitions are delivering extremely strong financial results . We are grateful to the healthcare practitioners and clinicians that provide outstanding care every day as well as the technology and administrative teams that support them . There are some key take - aways worth noting from these very strong results : firstly , Adjusted Gross Profit ( ¹ ) increased significantly by 615 % YoY , and secondly , we achieved Adjusted Gross Margin ( ¹ ) percentage of almost 49 % . Furthermore , during Q2 , we closed the acquisition of CRH , followed by the acquisition of MyHealth in Q3 which now puts us on track for a proforma annualized revenue run - rate of almost $ 400 million and an Adjusted EBITDA ( 2 ) run - rate approaching $ 100 million . " Mr. Shahbazi added , " In addition to the CRH and MyHealth acquisitions , we continued to be active with our corporate development activities . In Q2-2021 we completed the